Fears and Tears Insufficient to Warrant Interim Injunction

On March 24, 2016, Justice Russell dismissed TearLab’s motion for an interim injunction that sought to prevent I-Med Pharma Inc.  from marketing its i-Pen System prior to the disposition of TearLab’s motion for an interlocutory injunction. Canadian Patent No. 2,494,540 relates to systems for measuring the osmolarity of fluid samples. TearLab markets a system for...
Read More

Patent Listing Redux – Perfect Match Again Required

In Gilead Sciences, Inc. v. Canada (Health), Justice Heneghan of the Federal Court granted Apotex’s motion and concluded that Canadian Patent No. 2,261,619 was ineligible for listing on the Patent Register in respect of the combination drug product TRUVADA (emtricitabine/tenofovir disoproxil fumarate) pursuant to paragraph 4(2)(a) of the Unamended (pre-2015 amendments) Patented Medicines (Notice of...
Read More

Real and Substantial – Connection to B.C. sufficient for Canadian Olympic Committee to maintain action against North Face

On February 16, 2016, Justice Dillon dismissed an application by VF Outdoor Inc. (“VF USA”) to dismiss or stay the action brought against it by the Canadian Olympic Committee on the grounds that the Court lacked territorial competence or that the Court should decline to exercise its jurisdiction. The VF Corporation owns various VF Group...
Read More

LINGAYEN Trade-mark Cannot Be Preserved – Court of Appeal Clarifies Test for Marks Descriptive of Place of Origin

MC Imports Inc. appealed a decision of the Federal Court that invalidated its trade-mark for LINGAYEN in association with Filipino food products such as fish sauce, preserves, salted fish, and other related goods, as well as supplier and distributor services. The word “Lingayen” is the name of a municipality in the Philippines. The Federal Court,...
Read More

SUPERSHUTTLE Trade-mark Stops Here – Registered Services Must be Performed in Canada

In July 2014, the Trade-marks Opposition Board concluded that Supershuttle International Inc. had not used its registered trade-mark SUPERSHUTTLE in Canada. The mark was registered in association with “airport passenger ground transportation services.” The TMOB noted that while the evidentiary threshold for showing use is low, there must be sufficient facts demonstrating use in Canada. Supershuttle...
Read More

Federal Court allows application to correct ownership after inadvertent error in assignment of patent rights

On January 19, 2016 Justice Shore granted an application under section 52 of the Patent Act to vary all entries in the Patent Office related to the ownership of Canadian Patent No. 2,406,340 by recording Gray Manufacturing Company, Inc. as the owner. Gray Automotive Products Co. employed the named inventor of the 340 Patent, William...
Read More

Federal Court reaffirms disclosure requirement for sound prediction

In Eli Lilly Canada Inc v. The Minister of Health et al, 2016 FC 47, Justice Barnes dismissed Eli Lilly’s prohibition application in respect of Hospira’s generic version of pemetrexed. Canadian Patent No. 1,340,794 is directed to novel pyrrolopyrimidine derivatives which are useful as antitumor agents, the production and utilization thereof. The inventive concept of...
Read More

Federal Court of Appeal upholds prohibition application dismissal under s. 6(5)(b) of the NOC Regulations

Bayer Inc. et al., v. Fresenius Kabi Canada Ltd., 2016 FCA 13 Bayer appealed the dismissal of its application for a prohibition order against Fresenius in respect of the drug moxifloxacin hydrochloride. Prothonotary Lafrenière dismissed the application under s. 6(5)(b) of the Patented Medicines (Notice of Compliance) Regulations on the basis that Fresenius’ product monograph...
Read More

Claims under the Trade-marks and Competition Acts insufficient basis to stay Ontario defamation action

On December 22 2015, Justice Perell dismissed a motion to temporarily stay a defamation action in the Ontario Superior Court of Justice until completion of an action in the Federal Court involving the same parties and similar issues (2015 ONSC 7980). Canadian Standards Association sued Gordon Knight and his corporation in the Federal Court for...
Read More

Perks are for everyone: PERKOPOLIS mark found non-infringing

In Venngo Inc. v. Concierge Connection Inc. et al., 2015 FC 1338, Justice Manson dismissed Venngo’s claim that Concierge and its directors infringed Venngo’s marks ending with the word “PERKS”, by using the trade-mark PERKOPOLIS. He also dismissed the claims that the defendants made false and misleading statements discrediting Venngo’s business, committed the tort of...
Read More

Appeal dismissed from motion to compel answers from examination for discovery

In Hospira Healthcare Corporation v. The Kennedy Institute of Rheumatology, Madam Justice Kane dismissed Hospira’s appeal from Prothonotary Milczynski’s Order arising from a motion by Hospira to compel Kennedy to answers 354 questions that were taken under advisement or refused at the examination for discovery of Kennedy’s representative. The underlying dispute is a patent infringement...
Read More

Dismissal of Application for “SECRET” Trade-mark upheld by the Federal Court

On December 1, 2015, Justice Gascon of the Federal Court released the judgment and reasons in Eclectic Edge Inc. v. Gildan Apparel (Canada) LP 2015 FC 1332. The case was an appeal of the decision of the Registrar of Trade-marks, refusing Eclectic’s application to register four trade-marks containing the words “valentine” and “secret” in association...
Read More

Federal Court of Appeal refuses Appeal of Motion to Strike Decision due to “Uncertainty” in the Case Law

On December 8, 2015, Justice Stratas of the Federal Court of Appeal released his Reasons for Judgment of the Court in Teva Canada Limited v. Pfizer Canada Inc., 2015 FCA 280. The case was an appeal from the Federal Court (Justice Strickland) who dismissed an appeal from the Order of Prothonotary Aronovitch who dismissed Teva...
Read More

A Confluence of Two Streams – Subsequent Amalgamation Cannot Change Contracting Parties’ Intention

In April 2009, Pfizer and ratiopharm settled a prohibition application under the PM(NOC) Regulations in respect of the drug product ratio-sildenafil. Subsequent to the agreement, Teva Canada Limited amalgamated with Ratiopharm and remained Teva Canada Limited. In 2012, Teva successfully defended a prohibition application commenced against it in respect of Novo-Sildenafil. Teva then brought a...
Read More

Unauthorized changes to translation breaches contract but not moral rights

On November 17, 2015 Justice Hamilton of the Superior Court of Quebec released his judgment in Desgagné v. Group Ville-Marie Litterature Inc., 2015 QCCS 5448 a copyright/breach of contract dispute involving the unauthorized modification of a translated book prepared by Bernard Desgagné. Desgagné had entered into a contract with a publisher to prepare a translation...
Read More

Court dismisses first biologic prohibition application

Amgen brought this prohibition application to prevent the issuance of a Notice of Compliance to Apotex for its proposed filgrastim product. The order would last until the July 31, 2024 expiry of Amgen’s Canadian Patent No. 1,341,537, entitled “Production of Pluripotent Granulocyte Colony-Stimulating Factor” and which is listed on the Patent Register against Amgen’s filgrastim product, NEUPOGEN. Prior...
Read More

Going Down Swinging: Idenix’s Counterclaim for Infringement and Invalidity Dismissed as Own Patent Held Invalid

On November 2, 2015 Justice Annis released a 326-page decision holding that Canadian Patent No. 2,490,191 invalid (2015 FC 1156; see our blog post here). Gilead sells the antiviral drug sofosbuvir in Canada under the brand name Sovaldi, for use in combatting Hepatitis C virus (HCV). Gilead commenced an action to impeach 191 Patent because...
Read More